Vical, Incorporated (NASDAQ: VICL) has been awarded a $2 million Phase II small business technology transfer grant from the US National Institute of Allergy and Infectious Diseases department from the National Institues of Health.…
CombinatoRx, Incorporated (NASDAQ: CRXX) up 8% to $3.45 on no recent developments. The 52-week range is $3.11 to $7.37. Yesterday, the company hit a 52-week low so perhaps it had nowhere to go but…
Medarex Inc. (NASDAQ: MEDX) Saw shares plummet in pre-market trading. Pfizer Inc. (NYSE: PFE) has ended a Phase III clinical trial of tremelimumab in patients with advanced melanoma after a review of interim data…
Hansen Medical, Inc. (NASDAQ: HNSN) announced last night the pricing of a spot secondary offering via Morgan Stanley as the sole underwriter for the deal. The size indication of 2.5 million shares that had…
A company called BioTrove, Inc. has filed to come public via an initial public offering this morning. It has applied to take the proposed ticker of "BTRV" on NASDAQ. BioTrove has filed to sell…
Cell Genesys, Inc. (NASDAQ: CEGE) has announced a global alliance with Takeda Pharmaceutical Company Limited in Japan. The companies will develop and commercialize Cell Genesys’ GVAX immunotherapy for prostate cancer, which is the company’s…
Cell Therapeutics (NASDAQ: CTIC) has filed an open mixed securities shelf registration for up to $150 million. This will allow it to sell debt securities, common stock, preferred stock, and warrants. Last Tuesday, the…
Bentley Pharmaceuticals Inc. (NYSE: BNT) will be purchased by Teva Pharmaceutical Industries (NASDAQ: TEVA) for $360 million. Bentley shareholders will receive $15 per share and an undisclosed amount of shares in CPEX Pharmaceuticals, a…
Usually drug companies look forward to presenting data on their drugs and medical treatments. The the American College of Cardiology meeting was this weekend, and the findings and recommendations are worse than bad. Shares…
On tonight’s MAD MONEY on CNBC, Jim Cramer said he had a speculative biotech stock. His pick in the sector is AMAG Pharmaceuticals, Inc. (AMAG) because of its soon to be approved ferumoxytol, a…
Optimer Pharmaceuticals, Inc. (NASDAQ" OPTR) has filed an open shelf registration last night with the SEC that will allow it to sell up to $100 million in any of the following types of securities: …
Biotechs always have some news movers regardless of which direction the markets are headed. Here are some of the top movers in biotech today, although we would note that many of the largest market…
Baxter (NYSE: BAX) is probably retaining more lawyers. So far nineteen people have died from tainted Heparin, a blood-thinner. BAX is one of the largest marketers of the drug. According to The Wall Street…
Many biotech stocks are enjoying large gains Monday, although some are on no real breaking news. Here is a look at some notable gainers: Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) up $1.39 to $28.97, a…
Zogenix, Inc. filed last night to come public via an initial public offering of up to $86.25 million in securities sales. The company has applied to take the ticker "ZGNX" on NASDAQ. Banc of…